Search

everythinglearnresearchcommunity

for

Search:↓

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

MicroRNAs could lead to new treatments for skin diseases, but more research is needed.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Rituximab improved her dermatomyositis better than usual treatments.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

A new test using NOS2 and CCL27 genes can better diagnose and treat psoriasis and eczema.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.